Vyleesi® product results: 14% growth in prescriptions dispensed over prior quarter – 7 consecutive quarters of double digit growth. Click here to learn more ›

Efficacy and Impact of the Melanocortin Receptor Agonists PL8177 and PL9654 in an STZ-Rat Model of Diabetic Retinopathy

Scroll to Top